GlobeNewswire Inc.··NaVERAXA Biotech Secures $77.5M in Financing Ahead of NASDAQ Debut
VERAXA Biotech secures $77.5M through senior notes and Lincoln Park Capital Fund investment, preparing for NASDAQ debut as $VRXA following Voyager Acquisition merger.
VACHVACHUVACHWSPAC mergerfinancing